Metrikler
Yayın
11
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Araştırma Alanları
Sağlık Bilimleri
Makaleler
Tümü (11)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (8)
ESCI (1)
Scopus (8)
TRDizin (5)
2025
20251. Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast
Sali S., SALİ M., Caner B., Ocak B., ÇOBAN E., COŞKUN A., et al.
Oncologist
, cilt.30, sa.8, 2025 (SCI-Expanded, Scopus)
2025
20252. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
Kahraman S., Erul E., GÜMÜŞAY Ö., GÜVEN D. C., AKSOY S., BAŞARAN G., et al.
Clinical Breast Cancer
, cilt.25, sa.5, 2025 (SCI-Expanded, Scopus)
2025
20253. Hormon reseptörü pozitif, HER2 negatif metastatik meme kanseri tanısıyla ribosiklib veya palbosiklib ile letrozol kombinasyon tedavisi verilen hastalarda HER2-düşük ekspresyonunun önemi
kahraman s., Hizal M., Gumusay O., Basaran G., Seyyar M., Sahin E., et al.
Turkish Journal of Clinics and Laboratory
, cilt.16, sa.2, ss.255-262, 2025 (TRDizin)
2023
20234. Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment
ŞAHİN A. B., Caner B., Ocak B., Gulmez A., HAMİTOĞLU B., ÇUBUKÇU E., et al.
ONCOLOGY LETTERS
, cilt.26, sa.6, 2023 (SCI-Expanded, Scopus)
2022
20225. Platin-based chemotherapy does not improve survival in patients with non-metastatic resected typical carcinoid tumors
ŞAHİN A. B., MELEK H., OCAK B., OYUCU ORHAN S., ERKAN B., CANER B., et al.
MOLECULAR AND CLINICAL ONCOLOGY
, cilt.17, sa.4, 2022 (ESCI, Scopus)
2021
20216. The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans.
Adem D., Yazici S., Ozsen M., Cetintas S., Yalcinkaya U., Şahin A. B., et al.
Bosnian journal of basic medical sciences
, cilt.21, ss.174-178, 2021 (SCI-Expanded, Scopus)
2021
20217. The Importance of Platinum Sensitivity in Metastatic Malignant Pleural Mesothelioma Patients
OCAK B., ŞAHİN A. B., DAKİKİ B., ODMAN H. U., sağlam n. h., OYUCU ORHAN S., et al.
Eurasian Journal of Medical Investigation
, cilt.5, ss.89-94, 2021 (TRDizin)
2021
20218. Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data.
Oyucu Orhan S., Bilgehan Sahin A. B., Cubukcu E., Deligonul A., Ocak B., Orhan B., et al.
Bosnian journal of basic medical sciences
, cilt.21, ss.745-750, 2021 (SCI-Expanded, Scopus)
2020
20209. Tolvaptan in the Treatment of the Syndrome of Inappropriate Anti-Diuretic Hormone in Cancer Patients
OCAK B., ŞAHİN A. B., DAKİKİ B., CANER B., ERTAŞ H., OYUCU ORHAN S., et al.
Eurasian Journal of Medical Investigation
, cilt.4, sa.4, ss.490-494, 2020 (TRDizin)
2020
202010. Chemo-Immunotherapy with Atezolizumab in Extensive-Stage Small-Cell Lung Cancer; Single-Center Experience
ŞAHİN A. B., ÇUBUKÇU E., OCAK B., DELİGÖNÜL A., Kacan T., Orhan S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.30, sa.3, ss.148-154, 2020 (SCI-Expanded, Scopus, TRDizin)
2018
201811. Octreotide ameliorates dermal fibrosis in bleomycin-induced scleroderma
Oyucu Orhan S., Tektemur A., Gozel N., Ozercan I. H., Yolbas S., Yildirim A., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.48, sa.4, ss.886-891, 2018 (SCI-Expanded)